Stockreport

Proteostasis' PTI-428 a Breakthrough Therapy for cystic fibrosis [Seeking Alpha]

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
PDF Proteostasis' PTI-428 a Breakthrough Therapy for cystic fibrosisThe FDAdesignates Proteostasis Therapeutics' (NYSE:PTI) PTI-428 a Breakthrough Therapy for the treatment [Read more]